Matthias Ilmer

3.2k total citations · 1 hit paper
68 papers, 1.7k citations indexed

About

Matthias Ilmer is a scholar working on Oncology, Molecular Biology and Surgery. According to data from OpenAlex, Matthias Ilmer has authored 68 papers receiving a total of 1.7k indexed citations (citations by other indexed papers that have themselves been cited), including 39 papers in Oncology, 27 papers in Molecular Biology and 23 papers in Surgery. Recurrent topics in Matthias Ilmer's work include Pancreatic and Hepatic Oncology Research (25 papers), Cancer Cells and Metastasis (12 papers) and Pancreatitis Pathology and Treatment (8 papers). Matthias Ilmer is often cited by papers focused on Pancreatic and Hepatic Oncology Research (25 papers), Cancer Cells and Metastasis (12 papers) and Pancreatitis Pathology and Treatment (8 papers). Matthias Ilmer collaborates with scholars based in Germany, United States and China. Matthias Ilmer's co-authors include Eckhard Alt, Jody V. Vykoukal, Bernhard W. Renz, Jan DʼHaese, Jens Werner, Mitja L. Heinemann, Roland Kappler, Michael Berger, Maria A. Vorontsova and Jens Werner and has published in prestigious journals such as SHILAP Revista de lepidopterología, Cancer Research and Annals of Surgery.

In The Last Decade

Matthias Ilmer

64 papers receiving 1.7k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Advances in cancer immunotherapy 2019 – latest trends

2019 400 citations Stephan Krüger, Matthias Ilmer et al. profile →

Peers

Countries citing papers authored by Matthias Ilmer

Since Specialization

Citations

This map shows the geographic impact of Matthias Ilmer's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Matthias Ilmer with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Matthias Ilmer more than expected).

Fields of papers citing papers by Matthias Ilmer

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Matthias Ilmer. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Matthias Ilmer. The network helps show where Matthias Ilmer may publish in the future.

Co-authorship network of co-authors of Matthias Ilmer

This figure shows the co-authorship network connecting the top 25 collaborators of Matthias Ilmer. A scholar is included among the top collaborators of Matthias Ilmer based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Matthias Ilmer. Matthias Ilmer is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Mono-HOPE Versus Dual-HOPE in Liver Transplantation: A Propensity Score-Matched Evaluation of Early Graft Outcome 2025 ·Transplant International ·Dominik Koch, Mami Tamai, Malte Schirren, Moritz Drefs, (unknown), Christian M. Lange, Matthias Ilmer, Hanno Nieß, Bernhard W. Renz, (unknown), Markus Guba, Dionysios Koliogiannis	4
2	Bots in white coats: are large language models the future of patient education? A multicenter cross-sectional analysis 2025 ·International Journal of Surgery ·(unknown), (unknown), (unknown), (unknown), Michael Thomas, Thomas Schmidt, Christian Krautz, Christoph Kahlert, Sebastian Schölch, Martin K. Angele, Hanno Nieß, Markus Guba, Jens Werner, Matthias Ilmer, Bernhard W. Renz	4
3	Deep Learning‐Based MRI Volumetry for Living Kidney Donor Assessment: A New Tool for Predicting Post‐Donation Renal Function 2025 ·Clinical Transplantation ·Dominik Koch, (unknown), (unknown), Malte Schirren, (unknown), Tobias Seibt, Stephan Kemmner, Maximilian Scheifele, Matthias Ilmer, Bernhard W. Renz, Jens Werner, Manfred Stangl, Markus Guba, Dionysios Koliogiannis	1
4	Primary delayed gastric emptying after pylorus-resecting pancreatoduodenectomy: A matched-pair comparison of Roux-en-Y vs. Billroth-II reconstruction 2024 ·Surgery Open Science ·(unknown), (unknown), (unknown), (unknown), Elise Pretzsch, Maximilian Weniger, Jan DʼHaese, Bernhard W. Renz, Jens Werner, Matthias Ilmer	0
5	ChatGPT's Gastrointestinal Tumor Board Tango: A limping dance partner? 2024 ·European Journal of Cancer ·(unknown), (unknown), Clemens Gießen-Jung, Matthias Ilmer, Kristian Unger, (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown)	13
6	Hepatocellular Carcinoma: The Role of Surgery in Liver Cirrhosis 2024 ·Visceral Medicine ·Dominik Koch, (unknown), Matthias P. Fabritius, Jens Werner, Matthias Ilmer	1
7	In-vitro model to mimic T cell subset change in human PDAC organoid co-culture 2023 ·Journal of Cancer Research and Clinical Oncology ·Margit Knoblauch, Tao Ma, (unknown), Dominik Koch, (unknown), Kathrin Heinrich, (unknown), (unknown), C. Benedikt Westphalen, Hanno Nieß, Maximilian Reichert, Martin K. Angele, Ivonne Regel, Alexandr V. Bazhin, Jens Werner, Matthias Ilmer, Bernhard W. Renz	10
8	Pylorus resection versus pylorus preservation in pancreatoduodenectomy (PyloResPres): study protocol and statistical analysis plan for a German multicentre, single-blind, surgical, registry-based randomised controlled trial 2021 ·BMJ Open ·Bernhard W. Renz, Christine Adrion, Carsten Klinger, Matthias Ilmer, Jan DʼHaese, Heinz-J. Buhr, Ulrich Mansmann, Jens Werner	5
9	Effect of platelet inhibition with perioperative aspirin on survival in patients undergoing curative resection for pancreatic cancer: a propensity score matched analysis 2021 ·BMC Surgery ·Elise Pretzsch, Jan DʼHaese, Bernhard W. Renz, Matthias Ilmer, Tobias S. Schiergens, Rainer Christoph Miksch, Markus Albertsmeier, Markus Guba, Martin K. Angele, Jens Werner, Hanno Nieß	8
10	Targeting the Intestinal Barrier to Prevent Gut-Derived Inflammation and Disease: A Role for Intestinal Alkaline Phosphatase 2021 ·Visceral Medicine ·Florian Kühn, (unknown), Matthias Ilmer, Ulrich Wirth, Fatemeh Adiliaghdam, Tobias S. Schiergens, Joachim Andrassy, Alexandr V. Bazhin, Jens Werner	12
11	Prognostic Value of Preoperative Serum Carcinoembryonic Antigen and Carbohydrate Antigen 19-9 After Resection of Ampullary Cancer 2017 ·Journal of Gastrointestinal Surgery ·Tobias S. Schiergens, Bernhard W. Renz, Simone Reu, Jens Neumann, (unknown), Hanno Nieß, Matthias Ilmer, Stephan Krüger, Stefan Boeck, Volker Heinemann, Jens Werner, Axel Kleespies	8
12	Therapeutic Innovations for Targeting Hepatoblastoma 2016 ·Anticancer Research ·(unknown), Matthias Ilmer, Roland Kappler, Michael Berger	18
13	Role of N-acetylgalactosaminyltransferase 6 in early tumorigenesis and formation of metastasis 2016 ·Molecular Medicine Reports ·Friederike Liesche‐Starnecker, Alexandra C. Kölbl, Matthias Ilmer, Stefan Hutter, Udo Jeschke, Ulrich Andergassen	14
14	Improved Method for Isolation of Neonatal Rat Cardiomyocytes with Increased Yield of C-Kit+ Cardiac Progenitor Cells 2015 ·Journal of Stem Cell Research & Therapy ·(unknown), Matthias Ilmer, (unknown), Michael Coleman, Jody V. Vykoukal, Eckhard Alt	20
15	RSPO2 Enhances Canonical Wnt Signaling to Confer Stemness-Associated Traits to Susceptible Pancreatic Cancer Cells 2015 ·Cancer Research ·Matthias Ilmer, (unknown), Ivonne Regel, Kenji Yokoi, Christoph Michalski, Ignacio I. Wistuba, Jaime Rodriguez‐Canales, Eckhard Alt, Jody V. Vykoukal	59
16	Targeting the Neurokinin-1 Receptor Compromises Canonical Wnt Signaling in Hepatoblastoma 2015 ·Molecular Cancer Therapeutics ·Matthias Ilmer, (unknown), (unknown), Eckhard Alt, Dietrich von Schweinitz, Roland Kappler, Michael Berger	41
17	Glycosyltransferases as Markers for Early Tumorigenesis 2015 ·BioMed Research International ·Ulrich Andergassen, Friederike Liesche‐Starnecker, Alexandra C. Kölbl, Matthias Ilmer, Stefan Hutter, Klaus Friese, Udo Jeschke	22
18	Pancreatic CSCs and microenvironment 2015 ·Genes & Cancer ·Matthias Ilmer, David Horst	7
19	Detection and characterisation of disseminated tumour cells in bone marrow of breast cancer patients by immunostaining of Her-2 and MUC-1 in combination with Thomsen-Friedenreich (CD176). 2014 ·PubMed ·(unknown), (unknown), (unknown), Sabine Heublein, Stefan Hutter, Matthias Ilmer, Christian Schindlbeck, K Friese, Udo Jeschke	2
20	Detection of Breast Cancer Cells in Blood Samples by Immunostaining of the Thomsen–Friedenreich Antigen 2013 ·Future Oncology ·Ulrich Andergassen, (unknown), Alexandra C. Kölbl, Christian Schindlbeck, Matthias Ilmer, Stefan Hutter, Sabine Heublein, Brigitte Rack, Klaus Friese, Udo Jeschke	2

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact